|
|
|
|
|
HOME >
CORPORATE INFO > COMPANY BACKGROUND
|
|
|
|
Alivus Life Sciences Ltd.
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Glenmark |
|
|
|
BSE Code |
543322
|
|
ISIN Demat |
INE03Q201024
|
|
Book Value |
245.79
|
|
|
NSE Code |
ALIVUS
|
|
Dividend Yield % |
0.58
|
|
Market Cap |
105947.61
|
|
|
P/E |
19.98
|
|
EPS |
43.23
|
|
Face Value |
2
|
|
|
|
|
|
|
|
|
Incorporation Year
|
23-06 2011
|
|
Registered Office
|
Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth, Solapur, Maharashtra-413213 .
|
|
ISINNO
|
INE03Q201024
|
|
Phone
|
02189 234456/234246
|
|
E-mail
|
complianceofficer@alivus.com |
|
URL
|
www.alivus.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Hiren K Patel
|
|
Managing Director
|
Yasir Rawjee
|
|
Company Secretary
|
Rudalf Corriea
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|